ILCV Performance — iShares Morningstar Value ETF
Data updated: 2026-09-25
ILCV returned +12.46% year to date and +27.55% over one year to Jul 2026. Annualised returns are +17.40% over 3 years and +12.43% over 5 years. The fund beat its US Large Value category average: $100 invested three years ago grew to $162, against $156 for the category, and to $128 over one year, against $122. Volatility over the past three years was 11.27% a year. In the 12 months to Jul 2026 the fund took in a net $11.7M, and assets reached $1.32B.
ILCV Growth of $100
What $100 invested in iShares Morningstar Value ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Value category average over the same months.
| Period | ILCV | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $128 | $122 |
| 3 years (Aug 2023 – Jul 2026) | $162 | $156 |
| 5 years (Aug 2021 – Jul 2026) | $180 | $168 |
| Since data start (Aug 2019 – Jul 2026) | $227 | $226 |
ILCV Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +12.46% |
| 1 year | +27.55% |
| 3 years (annualised) | +17.40% |
| 5 years (annualised) | +12.43% |
ILCV Annual Returns
Calendar-year total returns of iShares Morningstar Value ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +12.46% |
| 2025 | +18.78% |
| 2024 | +17.12% |
| 2023 | +14.35% |
| 2022 | −6.97% |
| 2021 | +26.58% |
| 2020 | −0.86% |
| 2019 (Aug–Dec) | +8.86% |
ILCV Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.1% | +1.6% | −4.5% | +6.6% | +2.7% | −0.3% | +4.0% | — | — | — | — | — |
| 2025 | +3.7% | +0.7% | −3.2% | −3.1% | +2.5% | +3.6% | +0.7% | +4.6% | +2.9% | +1.9% | +3.3% | 0.0% |
| 2024 | +0.9% | +3.7% | +4.6% | −4.0% | +3.3% | +0.7% | +4.0% | +2.7% | +1.5% | −1.2% | +5.1% | −4.7% |
| 2023 | +4.7% | −3.5% | +0.6% | +1.6% | −3.0% | +6.1% | +4.0% | −2.4% | −3.5% | −3.0% | +7.4% | +5.4% |
| 2022 | −2.2% | −2.0% | +3.1% | −5.2% | +1.7% | −8.3% | +6.1% | −2.7% | −8.6% | +10.9% | +6.1% | −4.1% |
| 2021 | −1.6% | +4.8% | +6.6% | +3.7% | +2.2% | −0.5% | +1.1% | +1.9% | −3.7% | +5.3% | −2.1% | +6.7% |
| 2020 | −3.6% | −9.8% | −13.9% | +10.8% | +2.5% | −1.0% | +2.0% | +3.5% | −2.5% | −2.8% | +13.8% | +3.5% |
| 2019 | — | — | — | — | — | — | — | −2.8% | +4.7% | +1.9% | +2.6% | +2.3% |
ILCV Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 11.27%
- 3-year Sharpe ratio: 1.14 (vs 4.5% risk-free rate)
- Best month: +7.37% (Nov 2023)
- Worst month: −4.68% (Dec 2024)
ILCV Fund Flows
Monthly money in and out of iShares Morningstar Value ETF, from SEC Form N-PORT.
- 12-month net flow: $11.7M
- 12-month gross sales (incl. reinvestments): $326.1M
- Sales ÷ redemptions: 1.04×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $5.1M | $0 | $5.1M |
| Jun 2026 | $122.6M | $116.2M | $6.4M |
| May 2026 | $0 | $5.0M | −$5.0M |
| Apr 2026 | $4.9M | $4.9M | −$26K |
| Mar 2026 | $23.7M | $19.0M | $4.7M |
| Feb 2026 | $19.4M | $0 | $19.4M |
| Jan 2026 | $19.0M | $38.3M | −$19.3M |
| Dec 2025 | $131.3M | $117.9M | $13.4M |
| Nov 2025 | $0 | $0 | $0 |
| Oct 2025 | $9 | $0 | $9 |
| Sep 2025 | $0 | $4.4M | −$4.4M |
| Aug 2025 | $0 | $8.6M | −$8.6M |
ILCV Assets Under Management
Net assets of iShares Morningstar Value ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $1.32B |
| 2026-04-30 | $1.24B |
| 2026-01-31 | $1.18B |
| 2025-10-31 | $1.13B |
| 2025-07-31 | $1.05B |
| 2025-04-30 | $994.32M |
| 2025-01-31 | $1.05B |
| 2024-10-31 | $978.82M |
| 2024-07-31 | $948.52M |
| 2024-04-30 | $896.23M |
| 2024-01-31 | $882.63M |
| 2023-10-31 | $782.07M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.